Shares for the future: five factors I use to score shares

30th June 2023 16:02

by Richard Beddard from interactive investor

Share on

What makes you invest in one company and not another? Columnist Richard Beddard explains his approach to scoring companies and reveals a list of shares he considers good value. 

Number five 600

How do you weigh a global smartwatch and instrumentation company such as Garmin Ltd (NYSE:GRMN) against a local timber distributor like Latham (James) (LSE:LTHM)? It is not easy, but implicitly that is the kind of decision we make every time we choose to invest in one company and not to invest in another.

I get around this problem by scoring shares according to five factors I believe determine the potential of an investment for the long term. These factors carry near-equal weight in my spreadsheet, the Decision Engine, but that is not because they are of equal importance.

Where is the value?

The five factors are Profitability, Risks, Strategy, Fairness and Price. With the exception of price, each factor has an equal weight (they can score between 0 and +2).

Price works a bit differently, it can score between -2 and +1, which is why the maximum score for a share is 9 (2+2+2+2+1).

I chose this idiosyncratic system so price would have a bearing on trades, but it would not outweigh quality.

My main concern was to avoid paying too much for companies that scored highly on the four factors that determine the quality of the business, hence high prices are penalised more than low prices are rewarded.

When I rewarded the lowest priced companies with a score of +2 instead of +1, I found that cheap companies of dubious quality could leapfrog good businesses at reasonable prices in the Decision Engine list. Since I was after the latter, not the former, this was unhelpful.

Originally, I weighed the other four factors equally because it was easy, and although we are many years into this project now, I have no inclination to change things.

But, as I said, that is not because I believe they are equally important.

Investing through the rear-view mirror

Price and profitability are easy to analyse.

The price score only requires me to make one judgement: what period to use to normalise the earnings yield. Profit in one year is not necessarily indicative of what a company might earn in a typical year, so I try to incorporate good times and bad in my calculation.

The profitability score requires me to consider return on capital, profit margin, and cash flow over the same period, but I am just comparing them to benchmarks. I prefer the shares I invest in to be able to sustain a 10% return on capital through thick and thin, converting 75% of that profit into cash on average.

These factors are quantifiable, they are derived from audited data. There is a high level of standardisation in the data and how it is presented, and once the data is in the spreadsheet the scores take me seconds to determine.

The amorphous future

Risk, strategy, and fairness are, by comparison, very difficult to analyse. Companies have much more discretion about the information they present to us and much of it is anecdotal.

The biggest risks are the ones we cannot imagine, strategies are, or should be, unique to each business, and fairness, how a business treats its employees, suppliers, customers, and the rest of us, is perhaps hardest of all to determine.

Often, we are reliant on statistics produced by the company itself on, for example, employee retention and customer satisfaction. At worst, companies tell us nothing more than the boilerplate affirmations most of them sign up to.

Somewhere between are the ESG (environmental, social, and corporate governance) and remuneration reports. They hold the promise of disclosure, but they are so bloated it is hard to see the wood for the trees.

The level of judgement is much higher. Kicking the tyres, company visits, reading online reviews, and so on, can help but this is not hard data and our degree of confidence in the scores must be lower.

You might well ask why bother? I am not sure many investors get past price and a smattering of fundamental data. Life is a lot easier if you stick to the data, but I do not think it is more profitable.

Financial data is a commodity. It is readily available on websites and through specialist data providers. The diligent private investor can clean it up a bit, but I do not think we can get an edge against, say, quantitative funds.

Also, financial data is backward looking, and the future does not always repeat itself. We can extrapolate from it, there is a link, but it is weak, and although portfolios following simple quantitative analysis have been shown to perform modestly well over long periods of time, most of the value in companies is not apparent in the data.

It is hidden in the strategies and cultures of companies, which is where the other three factors come in: how a company intends to make more money, what could get in the way, and whether the spoils will be shared fairly.

These criteria are intangible, business people talk about them but they do not necessarily commit to them. They are also future-looking.

Scoring them is almost entirely about judgement, but get it right and these scores will have the most impact.

By keeping the scores equal in weight, I am hedging my bets, between what we know that is only modestly beneficial and what we can only impute but is highly significant.

Beyond the commodification of data, and the hidden value in strategy and culture, one more reason I am not solely guided by the numbers is personal.

To people with more mathematical minds, charts, patterns, and numbers are interesting enough in themselves. I, though, am fascinated by how we organise ourselves into groups to profit. I think it is one of the many amazing things about human beings.

26 Shares for the future

I re-score each share in the Decision Engine once a year, after the publication of the annual report.

Since the last update a month ago, 4imprint Group (LSE:FOUR), Next (LSE:NXT), and Macfarlane Group (LSE:MACF) have been through the process. To see how I scored them, or any share, please click on the share’s name in the table below.

Advanced Medical Solutions Group (LSE:AMS), Churchill China (LSE:CHH), and Bloomsbury Publishing (LSE:BMY) have all published annual reports and are due to be updated.

Generally, I consider shares that score 7 or more out of 9 to be good value. This month there are 26, the same as last month. Shares that score 5 or 6 out of nine are probably fairly priced.

0

Company

Description

Score

1

Focusrite

Designs recording equipment, loudspeakers, and instruments for musicians

9

2

Howden Joinery

Supplies kitchens to small builders

9

3

Churchill China

Manufactures tableware for restaurants and eateries

8

4

Dewhurst

Manufactures pushbuttons and other components for lifts and ATMs

8

5

RWS

Translates documents and localises software and content for businesses

8

6

Macfarlane

Distributor of protective packaging

8

7

James Latham

Imports and distributes timber and timber products

8

8

Porvair

Manufactures filters and filtration systems for fluids and molten metals

8

9

Bunzl

Distributes essential everyday items consumed by organisations

8

10

Auto Trader

Online marketplace for motor vehicles

7

11

FW Thorpe

Makes light fittings for commercial and public buildings, roads, and tunnels

7

12

Goodwin

Casts and machines steel. Processes minerals for casting jewellery, tyres

7

13

Quartix

Supplies vehicle tracking systems to small fleets and insurers

7

14

Advanced Medical Solutions

Manufactures surgical adhesives, sutures, fixation devices and dressings

7

15

Renishaw

Whiz bang manufacturer of automated machine tools and robots

7

16

Treatt

Sources, processes and develops flavours esp. for soft drinks

7

17

Anpario*

Manufactures natural animal feed additives

7

18

XP Power*

Manufactures power adapters for industrial and healthcare equipment

7

19

Victrex*

Manufactures PEEK, a tough, light and easy to manipulate polymer

7

20

Cohort*

Manufactures military technology, does research and consultancy

7

21

Garmin

Manufactures sports watches and instrumentation

7

22

PZ Cussons

Manufactures personal care and beauty brands

7

23

Bloomsbury Publishing

Publishes books, and digital collections for academics and professionals

7

24

Games Workshop

Manufactures/retails Warhammer models, licenses stories/characters

7

25

4Imprint

Sells promotional materials like branded mugs and tee shirts direct

7

26

Softcat

Sells hardware and software to businesses and the public sector

7

27

YouGov

Manufactures power adapters for industrial and healthcare equipment

6

28

James Cropper

Manufactures specialist paper, packaging and high-tech materials

6

29

D4t4*

Develops and integrates Customer Data Platforms

6

30

Hollywood Bowl

Operates tenpin bowling and indoor crazy golf centres

6

31

Oxford Instruments

Manufacturer of scientific equipment for industry and academia

6

32

Tristel

Manufactures disinfectants for simple medical instruments and surfaces

6

33

James Halstead*

Manufactures vinyl flooring for commercial and public spaces

6

34

Next*

Retails clothes and homewares

6

35

Solid State

Manuf's rugged computers, battery packs, radios. Distributes electronics

5

36

Tracsis

Supplies software and services to the transport industry

5

37

Marks Electrical

Online retailer of domestic appliances and TVs

5

38

Judges Scientific

Acquires and operates small scientific instrument manufacturers

5

39

Hotel Chocolat*

Chocolate maker and retailer

5

40

Jet2

Flies holidaymakers to Europe, sells package holidays

4

Scores and stats: Richard Beddard. Data: SharePad and annual reports

Richard Beddard is a freelance contributor and not a direct employee of interactive investor.   

Richard owns shares in most of the shares in the Decision Engine. He weights his portfolio so it owns bigger holdings in the higher scoring shares.

More information about Richard’s investment philosophy and how he implements it.

Contact Richard Beddard by email: richard@beddard.net or on Twitter: @RichardBeddard

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Disclosure

We use a combination of fundamental and technical analysis in forming our view as to the valuation and prospects of an investment. Where relevant we have set out those particular matters we think are important in the above article, but further detail can be found here.

Please note that our article on this investment should not be considered to be a regular publication.

Details of all recommendations issued by ii during the previous 12-month period can be found here.

ii adheres to a strict code of conduct.  Contributors may hold shares or have other interests in companies included in these portfolios, which could create a conflict of interests. Contributors intending to write about any financial instruments in which they have an interest are required to disclose such interest to ii and in the article itself. ii will at all times consider whether such interest impairs the objectivity of the recommendation.

In addition, individuals involved in the production of investment articles are subject to a personal account dealing restriction, which prevents them from placing a transaction in the specified instrument(s) for a period before and for five working days after such publication. This is to avoid personal interests conflicting with the interests of the recipients of those investment articles.

Related Categories

    UK sharesAIM & small cap sharesNorth America

Get more news and expert articles direct to your inbox